269 related articles for article (PubMed ID: 23174537)
1. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
[TBL] [Abstract][Full Text] [Related]
2. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
[TBL] [Abstract][Full Text] [Related]
4. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
Gagnon V; Van Themsche C; Turner S; Leblanc V; Asselin E
Apoptosis; 2008 Feb; 13(2):259-71. PubMed ID: 18071906
[TBL] [Abstract][Full Text] [Related]
5. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
[TBL] [Abstract][Full Text] [Related]
6. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
[TBL] [Abstract][Full Text] [Related]
7. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
[TBL] [Abstract][Full Text] [Related]
9. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
10. Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells.
Häggblad Sahlberg S; Mortensen AC; Haglöf J; Engskog MK; Arvidsson T; Pettersson C; Glimelius B; Stenerlöw B; Nestor M
Int J Oncol; 2017 Jan; 50(1):5-14. PubMed ID: 27878243
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of mitochondrial Smac release by Akt in chemoresistant ovarian cancer cells].
Yang XK; Wang JD; Wang SY; Zhang YX
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):259-62. PubMed ID: 18788627
[TBL] [Abstract][Full Text] [Related]
12. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
[TBL] [Abstract][Full Text] [Related]
13. RNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivo.
Zhou W; Fu XQ; Liu J; Yu HG
Regul Pept; 2012 Jun; 176(1-3):13-21. PubMed ID: 22387880
[TBL] [Abstract][Full Text] [Related]
14. Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin.
Lee MW; Kim DS; Min NY; Kim HT
Int J Cancer; 2008 May; 122(10):2380-4. PubMed ID: 18224693
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest.
Zhang D; Piao HL; Li YH; Qiu Q; Li DJ; Du MR; Tsang BK
Exp Mol Pathol; 2016 Jun; 100(3):506-13. PubMed ID: 27163202
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells].
Zhou Y; Wang SY; Yang XK; Wang HM
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):97-100. PubMed ID: 21575475
[TBL] [Abstract][Full Text] [Related]
17. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
[TBL] [Abstract][Full Text] [Related]
18. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
19. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
[TBL] [Abstract][Full Text] [Related]
20. Akt isoform specific effects in ovarian cancer progression.
Linnerth-Petrik NM; Santry LA; Moorehead R; Jücker M; Wootton SK; Petrik J
Oncotarget; 2016 Nov; 7(46):74820-74833. PubMed ID: 27533079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
